Utility of Tuberculosis Directly Observed Therapy Programs as Sites for Access to and Provision of Antiretroviral Therapy in Resource-Limited Countries

Friedland, Gerald; Karim, Salim Abdool; Karim, Quarraisha Abdool; Lalloo, Umesh; Jack, Christopher; Gandhi, Neel; El Sadr, Wafaa
June 2004
Clinical Infectious Diseases;6/1/2004 Supplement, Vol. 38, pS421
Academic Journal
The overwhelming share of the global human immunodeficiency virus (HIV) infection and disease burden is borne by resource-limited countries. The explosive spread of HIV infection and growing burden of disease in these countries has intensified the need to find solutions to improved access to treatment for HIV infection. The epidemic of HIV infection and acquired immune deficiency syndrome (AIDS) has been accompanied by a severe epidemic of tuberculosis. Tuberculosis has become the major cause of morbidity and mortality in patients with HIV disease worldwide. Among the various models of provision of HIV/AIDS care, one logical but unexplored strategy is to integrate HIV/AIDS and tuberculosis care and treatment, including highly active antiretroviral therapy, through existing tuberculosis directly observed therapy programs. This strategy could address the related issues of inadequate access and infrastructure and need for enhanced adherence to medication and thereby potentially improve the outcome for both diseases.


Related Articles

  • From Directly Observed Therapy to Accompagnateurs: Enhancing AIDS Treatment Outcomes in Haiti and in Boston. Behforouz, H. L.; Farmer, P. E.; Mukherjee, J. S. // Clinical Infectious Diseases;6/1/2004 Supplement, Vol. 38, pS429 

    Like tuberculosis, human immunodeficiency virus (HIV) disease is associated with poverty and social inequalities, conditions that hamper the delivery of care. Like tuberculosis, treatment of HIV infection requires multidrug regimens, and the causative agent acquires drug resistance, which can be...

  • Mortality and morbidity patterns among HIV patients with prognostic markers in a tertiary care hospital in southern India. Rajeev, A.; Sharma, A. // Australasian Medical Journal;May2011, Vol. 4 Issue 5, p273 

    Background Opportunistic infections are an important cause of morbidity and mortality in persons infected with HIV. In recent years, antiretroviral treatment (ART) and prophylaxis against various other opportunistic infections have contributed to a decrease in AIDS-related mortality. We...

  • Intensive Tuberculosis Screening for HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa. Bassett, Ingrid V.; Wang, Bingxia; Chetty, Senica; Giddy, Janet; Losina, Elena; Mazibuko, Matilda; Bearnot, Benjamin; Allen, Jenny; Walensky, Rochelle P.; Freedberg, Kenneth A. // Clinical Infectious Diseases;10/1/2010, Vol. 51 Issue 7, p823 

    Background. The World Health Organization (WHO) recommends cough as the trigger for tuberculosis screening in human immunodeficiency virus (HIV)-infected patients, with acid-fast bacillus (AFB) smear as the initial diagnostic test. Our objective was to assess the yield and cost of a more...

  • Misclassification of First-Line Antiretroviral Treatment Failure Based on Immunological Monitoring of HIV Infection in Resource-Limited Settings. Kantor, Rami; Diero, Lameck; DeLong, Allison; Kamle, Lydia; Muyonga, Sarah; Mambo, Fidelis; Walumbe, Eunice; Emonyi, Wilfred; Chan, Philip; Carter, E. Jane; Hogan, Joseph; Buziba, Nathan // Clinical Infectious Diseases;8/1/2009, Vol. 49 Issue 3, p454 

    Background. The monitoring of patients with human immunodeficiency virus (HIV) infection who are treated with antiretroviral medications in resource-limited settings is typically performed by use of clinical and immunological criteria. The early identification of first-line antiretroviral...

  • In-hospital mortality rates and HIV: a medical ward review, Lilongwe, Malawi. A. Akinkuotu; Roemer, E.; Richardson, A.; Namarika, D. C.; Munthali, C.; Bahling, A.; Hoffman, I. F.; Hosseinipour, M. C. // International Journal of STD & AIDS;Aug2011, Vol. 22 Issue 8, p465 

    In order to determine inpatient hospital mortality rates, causes of mortality and characteristics of inpatients at Kamuzu Central Hospital (KCH) in Lilongwe, Malawi, we conducted a prospective observational study of all patients admitted to KCH medical ward from 20 September 2008 to April 2,...

  • Bacterial Community Acquired Pneumonia in HIV-Infected Inpatients in the Highly Active Antiretroviral Therapy Era. Madeddu, G.; Porqueddu, E. M.; Cambosu, F.; Saba, F.; Fois, A. G.; Pirina, P.; Mura, M. S. // Infection;Jun2008, Vol. 36 Issue 3, p231 

    Highly active antiretroviral therapy (HAART) has deeply modified HIV/AIDS related morbidity and mortality. However, bacterial community acquired pneumonia (BCAP) still represents one of the most frequent causes of morbidity in HIV-infected patients with an inpatient 10% mortality rate. We...

  • Immunological and Virological Impact of Highly Active Antiretroviral Therapy Initiated during Acute HIV-1 Infection. Streeck, Hendrik; Jessen, Heiko; Galit Alter; Teigen, Nickolas; Waring, Mike T.; Jessen, Arne; Stahmer, Ingrid; van Lunzen, Jan; Lichterfeld, Mathias; Xiaojiang Gao; Allen, Todd M.; Carrington, Mary; Walker, Bruce D.; Rockstroh, Juergen K.; Altfeld, Marcus // Journal of Infectious Diseases;9/15/2006, Vol. 194 Issue 6, p734 

    The immunological and virological impact of short-term treatment initiated during acute human immunodeficiency virus type 1 (HIV-1) infection was assessed prospectively in 20 subjects, 12 of whom initiated highly active antiretroviral therapy (HAART) for 24 weeks and then terminated treatment....

  • Higher Baseline Levels of Plasma Human Immunodeficiency Virus Type 1 RNA Are Associated with Increased Mortality after Initiation of Triple-Drug Antiretroviral Therapy. Wood, Evan; Hogg, Robert S.; Yip, Benita; Quercia, Romina; Harrigan, P. Richard; O'Shaughnessy, Michael V.; Montaner, Julio S.G. // Journal of Infectious Diseases;11/15/2003, Vol. 188 Issue 10, p1421 

    Investigates the association between higher baseline levels of plasma human immunodeficiency virus type 1 RNA and increased mortality after initiation of triple-drug antiretroviral therapy. Determination of independent predictors of time to death using Cox regression; Adjustment of adherence to...

  • China reported 60% decrease in HIV-related mortality, yet far from overall goal. Smith, Stephen M. // Infectious Disease News;Jun2011, Vol. 24 Issue 6, p16 

    The article reports on a 60% reduction in HIV-related mortality from 2002 to 2009 and an increase in antiretroviral treatment coverage among those eligible for treatment in China.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics